搜索优化
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
房地产
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
时间不限
过去 1 小时
过去 24 小时
过去 7 天
过去 30 天
按相关度排序
按时间排序
Cure Today
42 分钟
Tips for Making a Thanksgiving Manageable With Cancer
When I felt inclined to spend a holiday alone during breast cancer treatment, I was encouraged to think of ways to make new ...
Cure Today
2 小时
Overcoming Hormone Therapy Resistance in Metastatic Breast Cancer
An expert discusses the next steps for patients with metastatic breast cancer after their disease no longer responds to ...
Cure Today
20 小时
Parenting and Cancer: How Much Do Kids Need to Know?
Musician Danielia Cotton and her partner, attorney Sam Roberts, discuss how much they’ve shared with their daughter about ...
Cure Today
22 小时
Itovebi Combo May Improve Survival in Metastatic Breast Cancer Subtype
An Itovebi regimen demonstrated significantly longer progression-free survival compared with placebo in some with metastatic ...
Cure Today
1 天
The Importance of Gratitude During Cancer, Not Only in November
Gratitude was not something I learned in childhood. Well, I learned when to say, “Please” and “Thank you,” but I didn’t ...
Cure Today
1 天
FDA Accepts New Drug Application for Nubeqa Combo for Prostate Cancer Subset
The FDA will review an application to consider potential approval of Nubeqa plus androgen deprivation therapy for metastatic ...
Cure Today
1 天
Focusing Research on T-Cell ALL to Further Treatment Options
An expert highlighted unmet needs in treating T-cell acute lymphoblastic leukemia and where research may focus in the future.
Cure Today
2 天
A Survivor's Thanksgiving: Celebrating Life's Blessings Post-Cancer
Celebrating Thanksgivings after cancer has made me appreciate all aspects of life even more and to truly cherish times of ...
Cure Today
2 天
Opdivo Combo Shows Better Survival Benefits in Advanced Hodgkin Lymphoma
Patients with advanced Hodgkin lymphoma demonstrated significantly improved survival benefits with an Opdivo regimen versus ...
Cure Today
1 天
Opdivo May Improve Outcomes in High-Risk Muscle-Invasive Bladder Cancer
Adjuvant Opdivo showed a significant improvement in overall survival and disease-free survival for patients with high-risk ...
Cure Today
2 天
Understanding Treatment Sequences in Managing R/R CLL
For patients with relapsed or refractory CLL, an expert explained that it’s important to understand the order of how ...
Cure Today
6 天
FDA Approves Ziihera for Some With Biliary Tract Cancer
The agency has approved Ziihera for adults with previously treated, unresectable or metastatic HER2-positive biliary tract ...
当前正在显示可能无法访问的结果。
隐藏无法访问的结果
反馈